IASLC faculty members from Europe, Asia and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced-stage lung cancer during the COVID-19 global pandemic. The faculty will share their experience and advice on 1) how COVID-19 impacts their patient population, 2) changes made in the management of current and newly diagnosed lung cancer patients due to pandemic, including starting and stopping treatment and monitoring, 3) testing for COVID-19, and 4) outcomes of COVID-19 positive lung cancer patients.
Participants
Dr. Suresh S. Ramalingam (Moderator), Dr. Federico Cappuzzo and Dr. Caicun Zhou
